These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8570727)
1. In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. Lee LK; Whitehurst C; Pantelides ML; Moore JV Photochem Photobiol; 1995 Nov; 62(5):882-6. PubMed ID: 8570727 [TBL] [Abstract][Full Text] [Related]
2. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy. Aniola J; Selman SH; Lilge L; Keck R; Jankun J Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328 [TBL] [Abstract][Full Text] [Related]
3. In vivo laser light distribution in human prostatic carcinoma. Whitehurst C; Pantelides ML; Moore JV; Brooman PJ; Blacklock NJ J Urol; 1994 May; 151(5):1411-5. PubMed ID: 8158797 [TBL] [Abstract][Full Text] [Related]
4. Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT. Lilge L; Pomerleau-Dalcourt N; Douplik A; Selman SH; Keck RW; Szkudlarek M; Pestka M; Jankun J Phys Med Biol; 2004 Jul; 49(14):3209-25. PubMed ID: 15357193 [TBL] [Abstract][Full Text] [Related]
5. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy. Jankun J; Lilge L; Douplik A; Keck RW; Pestka M; Szkudlarek M; Stevens PJ; Lee RJ; Selman SH J Urol; 2004 Aug; 172(2):739-43. PubMed ID: 15247773 [TBL] [Abstract][Full Text] [Related]
6. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. Selman SH; Albrecht D; Keck RW; Brennan P; Kondo S J Urol; 2001 May; 165(5):1795-801. PubMed ID: 11342978 [TBL] [Abstract][Full Text] [Related]
7. Laser dosimetry studies in the prostate. Chen Q; Hetzel FW J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
9. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM Photochem Photobiol; 2005; 81(1):96-105. PubMed ID: 15535736 [TBL] [Abstract][Full Text] [Related]
10. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH BJU Int; 2005 Jun; 95(9):1237-44. PubMed ID: 15892808 [TBL] [Abstract][Full Text] [Related]
11. Interstitial photodynamic therapy in the canine prostate. Lee LK; Whitehurst C; Chen Q; Pantelides ML; Hetzel FW; Moore JV Br J Urol; 1997 Dec; 80(6):898-902. PubMed ID: 9439405 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153 [TBL] [Abstract][Full Text] [Related]
13. Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours. Shackley DC; Whitehurst C; Moore JV; George NJ; Betts CD; Clarke NW BJU Int; 2000 Oct; 86(6):638-43. PubMed ID: 11069369 [TBL] [Abstract][Full Text] [Related]
14. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729 [TBL] [Abstract][Full Text] [Related]
16. In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy. Zhu TC; Hahn SM; Kapatkin AS; Dimofte A; Rodriguez CE; Vulcan TG; Glatstein E; Hsi RA Photochem Photobiol; 2003 Jan; 77(1):81-8. PubMed ID: 12856887 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog. Ross HM; Smelstoys JA; Davis GJ; Kapatkin AS; Del Piero F; Reineke E; Wang H; Zhu TC; Busch TM; Yodh AG; Hahn SM J Surg Res; 2006 Oct; 135(2):323-30. PubMed ID: 16650871 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits. Hill RA; Crean DH; Doiron DR; Ghosheh F; Ryan JA; Kelly H; Booth M; Liaw LH; Newman L; Berns MW Ophthalmic Surg Lasers; 1997 Nov; 28(11):948-53. PubMed ID: 9387183 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. Pantelides ML; Whitehurst C; Moore JV; King TA; Blacklock NJ J Urol; 1990 Feb; 143(2):398-401. PubMed ID: 2299739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]